As practices adopt the Oncology Care Model, practices should consider how this change will influence the practice and make efforts to continue engaging with the staff during this process, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
As practices adopt the Oncology Care Model, practices should consider how this change will influence the practice and make efforts to continue engaging with the staff during this process, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
Transcript (slightly modified)
The Oncology Care Model requires major changes to how a practice operates. How can they more easily make the transition?
I think a key thing in practice transformation is really understanding what the experience is like for your staff. I think talking with them and really getting their feedback as you are going through this kind of change is really a fundamental importance.
One of the practices that I work with very closely, they have a phrase inside that basically summarizes to “and just one more thing.” That kind of means that with all this change going on, they are always asked to do “and just one more thing,” and each thing may not seem really big but they just keep adding up and adding up and adding up. I think it is really important to engage your staff, engage your nurses, your care coordinators, and really understand what their experience is like and really learn from them about what’s needed to change the way the practice functions.
Are practices participating in OCM often participating in other payment models? If so, how does that impact the practice?
Yeah, I think that the issue between commercial and OCM is a really important one. Many of the participants are in multiple models and I think that creates some tension at times, but I think it also creates alignment because it enables people to use their care coordination function more broadly and develop economies of scale. So, I think there’s been really positive alignment for many of them. There are differences between the different models and I think that’s something the Community Oncology Alliance has provided a great deal of leadership on, trying to align that to reduce the complexity of implementing the different payment models that we see in the public sector and private sector.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More